cardiovascular and respiratory disorders Flashcards

1
Q

attributing factors to heart disease in pregnancy

A

-congenital heart disease
-lifestyle trends (smoking, alcohol, obesity, DM, HTN)
-chronic medical conditions
-obstetric conditions (twins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

physiologic changes in pregnancy that contribute to cardiac disease (4)

A

-increased blood volume
-decreased systemic vascular resistance (because of progesterone)
-hypercoagulability
-fluctuations in cardiac output (especially during labor and birth)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when does blood volume reach max during antepartum (highest risk cardiac complications)

A

32 weeks gestation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 conditions affected most by increased blood volume during pregnancy

A

-stenotic heart valves
-impaired ventricular function
-congenital artery disease (marfans; coarctation of aorta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 conditions affected most by decreased systemic vascular resistance

A

-abnormal connection between R and L heart (septal defect)
-shunts (uncorrected patent arteriosus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 conditions affected most by hypercoagulability

A

-artificial valves
-some arrhythmias and cardiac defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2 conditions affected most by fluctuations in cardiac output

A

-conditions that require constant blood volume (pulmonary HTN)
-conditions with fixed cardiac output (mitral stenosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

new york heart association heart failure classification (4 classes)

A

class 1: no limitation physical activity

class 2: slight limitation physical activity, comfortable at rest

class 3: marked limitation on physical activity

class 4: severe limitation and discomfort with any physical activity, discomfort present at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

modified WHO classification heart failure (5 groups)

A

group 1: no increase in mortality, “mild” increase in morbidity

group 2: small increase mortality, moderate increase in morbidity

group 2.5: moderate increase mortality and morbidity

group 3: significant increased risk mortality and severe morbidity, expert counseling needed

group 4: extremely high risk mortality and severe morbidity, pregnancy contraindicated, termination recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

4 congenital heart diseases that are complicated with pregnancy

A

-septal defects/patent ductus arteriosus
-eisenmenger’s syndrome
-tetralogy of fallot
-aortic disease (coarctation, marfans)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 acquired heart diseases that are complicated with pregnancy

A

-valve disease (stenosis, MVP, rheumatic)
-ischemic disease
-cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

complications of septal defects/intracardiac shunts during pregnancy

A

-arrhythmias
-paradoxical embolism
-congestive heart failure
-VSD and PDA: pulmonary HTN, aortic regurgitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

complication of uncorrected defect VSD or PDA)

A

eisenmenger syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

complications of eisenmenger syndrome with pregnancy

A

-pulmonary HTN
-RV hypertrophy
-R to L shunting w cyanosis
(poor pregnancy outcomes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

complications of tetralogy of fallot with pregnancy (corrected v uncorrected)

A

corrected:
-arrhythmias
-heart failure

uncorrected:
-R to L shunting exacerbated by decreased systemic vascular resistance of pregnancy (could result in eisenmengers)
-risk proportional to degree of shunting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

complications of marfans syndrome with pregnancy

A

-aortic wall weakness
-increased blood volume and CO of pregnancy exacerbates syndrome
-autosomal dominant
-enlarged aortic root/valve involvement = severe risk (surgical correction prn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

complications of coarctation of aorta with pregnancy

A

-upper extremity HTN
-lower extremity hypoTN
-complicated = high/major risk, aortic dissection, aneurysm, rupture most common
*needs correcting prior to pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

complications of mitral valve prolapse with pregnancy

A

-(rare) palpitations or arrhythmias
generally tolerate pregnancy and birth well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

complications of mitral stenosis (rheumatic) with pregnancy

A

-peripartum hemodynamic changes lead to ventricular failure and pulmonary edema
-afib
-pulmonary edema
-R sided HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

complications of bioprosthetic valves with pregnancy

A

-don’t require anticoagulants during pregnancy
-low rate complications during pregnancy
-not as durable, pregnancy accelerates deterioration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

are anticoagulants needed for bioprosthetic valves or mechanical

A

mechanical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

problem with heparin during pregnancy

A

-increased risk fetal/maternal bleeding during pregnancy
-increased risk PPH
-increased risk intraventricular brain hemorrhage in fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

problem with warfarin during pregnancy

A

teratogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

when do you stop anticoagulant (if needed for mechanical valve) when pregnant

A

2 weeks before labor

25
Q

what anticoagulants are given during pregnancy if needed for mechanic valves

A

-LMW heparin (lovenox) during 1st tri
-warfarin during 2nd and 3rd tri

26
Q

diagnosis ischemic heart disease (2 enzymes)

A

troponin I and T
(other enzymes not reliable during pregnancy)

27
Q

management ischemic heart disease during pregnancy

A

-thrombolytic agents contraindicated
-stents (need for anticoagulants can be issue)

intrapartum:
-lateral positioning
-epidural
-vaginal delivery preferred
-shortened 2nd stage labor (forceps, vacuum)

28
Q

when is maternal mortality rates highest (due to MI) for pregnant women with ischemic heart disease

A

within 2 weeks of birth

29
Q

between what time frame is cardiomyopathy considered peripartum cardiomyopathy

A

1 month before birth up to 5 months after birth
(congestive heart failure, EF<45%)

30
Q

management peripartum cardiomyopathy

A

-diuretics
-b blockers
-inotropic agents
-vasodilators

31
Q

complication with peripartum cardiomyopathy

A

recurs and gets worse with subsequent pregnancies (important that ventricle returns to normal before next pregnancy)

32
Q

3 things used to determine risk for cardiovascular perinatal morbidity and mortality

A

-specific disease/lesion
-functional abnormality produced
-development of complications

33
Q

4 categories within predictors of cardiac events risk assessment

A

-prior cardiac event before pregnancy
-NYHA class 3 or 4 or cyanotic
-left outflow obstruction
-systemic ventricular dysfunction

predictors = risk cardiac event
0 predictors = 5% risk
1 predictor = 27% risk
>1 predictor = 75% risk

34
Q

other parameters within cardiac risk assessment during pregnancy

A

-BNP (increased = increased risk HF)
-NT-proBNP

35
Q

antepartum assessment: red flags (7)

A

-SOB at rest
-severe orthopnea (4 pillows)
-resting HR>120
-Sbp >160
-RR>30
-O2 sat <94% w/ or w/o h/o CVD
-frequent syncope

36
Q

interventions during antepartum to decrease cardiac risk

A

-minimize workload
-teach signs of heart failure to report
-teach signs thromboembolism
-treat infections
-prevent anemia (promote nutrition)
-teach about meds
-continue to assess NYHA functional status

37
Q

intrapartum interventions to decrease cardiac risk

A

-O2
-positioning (lateral!)
-prevent hypoTN and HTN (tricky w epidural)
-strict manage fluids
-second stage labor: no valsalva, no pushing
-Abx prn

38
Q

late intrapartum/postpartum interventions to decrease cardiac risk

A

-monitor for cardiac decomp with autotransfusion PP
-monitor for infection
-activity as ordered/tolerated
-prevent constipation and valsalva
-discharge planning (cardiac decomp risk for 2 weeks)

39
Q

4 big resp complications in pregnancy

A

-asthma
-pneumonia
-pulmonary edema
-cystic fibrosis

40
Q

complications of asthma during pregnancy

A

-preterm labor
-SGA/IUGR
-preeclampsia
-C/S
-increased risk fetal death (if not controlled)

41
Q

management asthma during pregnancy

A

-prevent hypoxic events:
-monitor lung functions (PEFR)
-avoid/control triggers
-meds (rescue SABA, maintenance inhaled corticosteroids)

42
Q

preferred rescue med for asthma during pregnancy
preferred maintenance med for asthma during pregnancy

A

rescue: SABA
maintenance: inhaled corticosteroids

43
Q

intrapartum interventions for asthma

A

-continue meds
-position: semi/high fowlers (w hip tilt)
-I&O, avoid fluid overload

44
Q

contraindicated meds for asthmatic pregnant women

A

demerol
morphine
(both release histamine)

45
Q

postpartum interventions for asthma

A

-continue meds
-anticipate PPH (SABA meds relax uterus)
-avoid methergine and hemabate
-if bleeding: oxytocin and prostaglandin E w resp monitoring

46
Q

what postpartum meds are contraindicated for asthmatic women (2)

A

-methergine (vasoconstrictor)
-hemabate

47
Q

3 types pneumonia

A

-bacterial
-aspiration (w general anesthesia or seizures)
-viral (most common pregnant women)

48
Q

complications with pneumonia during pregnancy

A

-*preterm labor and birth
-bacteremia
-pneumothorax
-afib
-resp failure
-SGA neonate
-neonatal death

49
Q

pregnancy considerations with pneumonia - chest xray? Abx?

A

-chest xray is appropriate for Dx
-appropriate choice and dose Abx (least teratogenic effect, esp during 1st tri)

50
Q

management pneumonia during pregnancy

A

-prevention with vaccines and clear liquids during labor
-O2 (95%+ O2)
-semi/high fowlers with tilt
-antipyretics
-hydration
-management pain, anxiety, fatigue
-watch for preterm labor

51
Q

2 types pulmonary edema

A

-hydrostatic (cardiogenic, CHF) - hypervolemia
-vascular permeability (nonhydrostatic, noncardiogenic) - caused by sepsis, hypovolemia

52
Q

risks pulmonary edema with pregnancy

A

-increased blood volume and CO
-decreased plasma COP
-increased risk aspiration
-preeclampsia
-tocolysis
-hemorrhage

53
Q

management pulmonary edema in pregnancy

A

-O2 >95%

positioning:
-hydrostatic: upright w wedge
-vascular permeability: lateral

-IV morphine
-monitor I&O
-administer diuretics for hydrostatic

54
Q

positioning for pulmonary edema during pregnancy
-hydrostatic
-vascular permeability

A

-hydrostatic: upright w wedge
-vascular permeability: lateral

55
Q

major contraindication during l&d for IV morphine

A

about to deliver (resp depression in baby)

56
Q

preconceptual assessments cystic fibrosis

A

-lung function
-nutrition (90% ideal body weight)
-autosomal recessive (test dad)

57
Q

possible complications of cystic fibrosis during pregnancy

A

-chronic hypoxia
-inadequate nutrition
-frequent pulmonary infections
-fetal/neonatal complications (IUGR, preterm birth, fetal death)

58
Q

management cystic fibrosis during pregnancy

A

-aggressive Tx IV Abx for pulmonary infections
-continue chest physio and drainage
-nutrition: enteral/parenteral feedings prn
-pancreatic enzyme replacement prn
-monitor for and treat diabetes (more common)
-antenatal testing start @28-32 weeks
-preterm birth if maternal lung function deteriorates
-epidural
-vaginal birth
-breastfeeding (if sodium content is normal)